AR015917A1 - Composiciones de materia que contiene sertralina y procedimiento para aumentar su solubilidad en un medio acuoso - Google Patents

Composiciones de materia que contiene sertralina y procedimiento para aumentar su solubilidad en un medio acuoso

Info

Publication number
AR015917A1
AR015917A1 ARP980103146A ARP980103146A AR015917A1 AR 015917 A1 AR015917 A1 AR 015917A1 AR P980103146 A ARP980103146 A AR P980103146A AR P980103146 A ARP980103146 A AR P980103146A AR 015917 A1 AR015917 A1 AR 015917A1
Authority
AR
Argentina
Prior art keywords
solubility
sertralin
compositions
procedure
matter
Prior art date
Application number
ARP980103146A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR015917(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR015917A1 publication Critical patent/AR015917A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ARP980103146A 1997-07-01 1998-06-29 Composiciones de materia que contiene sertralina y procedimiento para aumentar su solubilidad en un medio acuoso AR015917A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
AR015917A1 true AR015917A1 (es) 2001-05-30

Family

ID=21971159

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP980103146A AR015917A1 (es) 1997-07-01 1998-06-29 Composiciones de materia que contiene sertralina y procedimiento para aumentar su solubilidad en un medio acuoso
ARP030102179A AR040279A2 (es) 1997-07-01 2003-06-19 Composiciones que contiene sal de sertralina
ARP030102180A AR040280A2 (es) 1997-07-01 2003-06-19 Procedimiento para aumentar su solubilidad en un medio acuoso

Family Applications After (2)

Application Number Title Priority Date Filing Date
ARP030102179A AR040279A2 (es) 1997-07-01 2003-06-19 Composiciones que contiene sal de sertralina
ARP030102180A AR040280A2 (es) 1997-07-01 2003-06-19 Procedimiento para aumentar su solubilidad en un medio acuoso

Country Status (34)

Country Link
EP (1) EP0999829A1 (id)
JP (1) JP2000514100A (id)
KR (1) KR100366373B1 (id)
CN (1) CN1261794A (id)
AP (1) AP1192A (id)
AR (3) AR015917A1 (id)
AU (1) AU742535B2 (id)
BG (1) BG103918A (id)
BR (1) BR9810739A (id)
CA (1) CA2290974C (id)
CO (1) CO4940495A1 (id)
DZ (1) DZ2548A1 (id)
EA (1) EA002481B1 (id)
HN (1) HN1998000102A (id)
HR (1) HRP980377A2 (id)
HU (1) HUP0002236A3 (id)
ID (1) ID23429A (id)
IL (1) IL133076A (id)
IS (1) IS5260A (id)
MA (1) MA24587A1 (id)
NO (1) NO996520L (id)
OA (1) OA11243A (id)
PA (1) PA8454301A1 (id)
PE (1) PE97199A1 (id)
PL (1) PL337804A1 (id)
SK (1) SK181099A3 (id)
TN (1) TNSN98124A1 (id)
TR (1) TR199903297T2 (id)
TW (1) TW550087B (id)
UA (1) UA67741C2 (id)
UY (1) UY25071A1 (id)
WO (1) WO1999001120A1 (id)
YU (1) YU68299A (id)
ZA (1) ZA985708B (id)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU784340B2 (en) 1999-12-23 2006-03-16 Pfizer Products Inc. Pharmaceutical compositions providing enhanced drug concentrations
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
EP1313473A2 (en) 2000-08-30 2003-05-28 Pfizer Products Inc. Sustained release formulations for growth hormone secretagogues
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
WO2008110268A1 (en) * 2007-03-12 2008-09-18 Dsm Ip Assets B.V. Cosmetic compositions
EP2520299A1 (en) * 2009-12-29 2012-11-07 Kowa Co., Ltd. Solid pharmaceutical composition for oral administration
EP2520300A4 (en) * 2009-12-29 2013-05-08 Kowa Co PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
CN109908354A (zh) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 盐酸舍曲林口服浓缩液及其制备工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
DE69004529T2 (de) * 1989-08-30 1994-02-24 Pfizer Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen.
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
EP0999829A1 (en) 2000-05-17
CO4940495A1 (es) 2000-07-24
CN1261794A (zh) 2000-08-02
DZ2548A1 (fr) 2003-02-08
CA2290974A1 (en) 1999-01-14
BR9810739A (pt) 2000-09-12
AU7544898A (en) 1999-01-25
HUP0002236A2 (hu) 2003-08-28
KR100366373B1 (ko) 2003-01-14
EA199900962A1 (ru) 2000-08-28
PA8454301A1 (es) 2000-09-29
OA11243A (en) 2003-07-24
IS5260A (is) 1999-11-19
YU68299A (sh) 2002-06-19
EA002481B1 (ru) 2002-06-27
AR040280A2 (es) 2005-03-23
IL133076A0 (en) 2001-03-19
ZA985708B (en) 2000-01-10
NO996520D0 (no) 1999-12-28
TNSN98124A1 (fr) 2005-03-15
BG103918A (en) 2000-07-31
UY25071A1 (es) 2000-12-29
KR20010013365A (ko) 2001-02-26
ID23429A (id) 2000-04-20
WO1999001120A1 (en) 1999-01-14
AP9801280A0 (en) 1998-06-30
AP1192A (en) 2003-07-23
AU742535B2 (en) 2002-01-03
HRP980377A2 (en) 1999-04-30
UA67741C2 (uk) 2004-07-15
IL133076A (en) 2003-12-10
HN1998000102A (es) 1999-01-08
PE97199A1 (es) 1999-10-05
CA2290974C (en) 2004-04-27
TW550087B (en) 2003-09-01
MA24587A1 (fr) 1998-12-31
JP2000514100A (ja) 2000-10-24
NO996520L (no) 2000-02-29
TR199903297T2 (xx) 2000-07-21
HUP0002236A3 (en) 2003-12-29
PL337804A1 (en) 2000-09-11
AR040279A2 (es) 2005-03-23
SK181099A3 (en) 2000-07-11

Similar Documents

Publication Publication Date Title
AR000714A1 (es) Un metodo de uso de un agente quelante para mejorar la fidelidad de color de telas lavadas y una composicion para uso en dicho metodo.
AR010579A1 (es) Composicion de limpieza y desinfeccion acuosa lista para usar y proceso para desinfeccion de superficies duras.
AR033215A2 (es) Composicion herbicida concentrada que contiene solucion acuosa de sales de potasio y monoetanolamina de glifosato y un agente tensioactivo
ES527150A0 (es) Un procedimiento para la preparacion de una solucion desinfectante acuosa de peroxido de hidrogeno.
MY122621A (en) Compositions containing a high percent saturation concentration of antibacterial agent
NO990160L (no) Anvendelse av en kombinasjon av surfaktanter, chelaterende midler og essensielle oljer for effektiv desinfeksjon
ATE312593T1 (de) Hautreinigungsmittel zur entfernung von tinte
BR9509720A (pt) Processo para a preparação de pequenas partículas compreendendo um composto orgânico cuja solubilidade é maior em um primerio solvente miscível em água que em um segundo solvente que é aquoso e uso das pequenas partículas
DK566686A (da) Rensning og/eller desinfektion af kontaktlinser
EA199900749A1 (ru) Фармацевтическая композиция
ES2175332T3 (es) Dentifrico anticalculos que contiene pirofosfato altamente soluble.
AR015917A1 (es) Composiciones de materia que contiene sertralina y procedimiento para aumentar su solubilidad en un medio acuoso
ES526823A0 (es) Procedimiento para la obtencion de agente de limpieza acuosos estables
ES2098964T3 (es) Concentrados colables liquidos acuosos de agente de limpieza ii.
MX173001B (es) Composiciones detergentes liquidas para superficie dura que contienen agente tensioactivo detergente ionico de zwitter y monoetanolamina y/o beta-aminoalcanol
ES2051461T3 (es) Medios de contraste.
AR004315A1 (es) Composicion que comprende el producto precipitado en la mezcla de una sal metalica soluble y uno o mas compuestos que tienen un componente seleccionadode silicatos, fosfatos o boratos y metodo para el control de drenaje y/o retencion de agua en la formacion de una matriz de papel y para el tratamiento
KR930019808A (ko) 세정제 조성물
BG103739A (en) Aqueous pharmaceutical composition containing hard soluble active substance in water
KR920014474A (ko) 담석 붕괴용 제제
ES2046422T3 (es) Composicion antimicrobiana y metodo de uso.
FR2803205B1 (fr) Solutions ioniques aqueuses et leurs utilisations notamment en ophtalmologie
AR020703A1 (es) Barra de limpieza de superficies duras.
NZ332907A (en) Toilet cleansing block containing greater than 3% of a binder selected from cellulose binder or gum
ES2196814T3 (es) Preparacion desinfectante que contiene cloro en alcohol.

Legal Events

Date Code Title Description
FC Refusal